Publication | Open Access
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease
73
Citations
6
References
2021
Year
ImmunodeficienciesImmunologyImmunodominanceAntibody ResponseVaccine HesitancyCovid-19Tumor ImmunologyVaccine TargetVaccine SurveillanceVaccine TrialCovid-19 VaccinationVaccinologyVaccine SafetyVaccine TestingHumoral ImmunityT Cell ImmunityHematologic Malignant DiseaseVaccinationPrecision VaccinologyVaccine EfficacyFda-authorized Covid-19 VaccinesMedicine
This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
| Year | Citations | |
|---|---|---|
Page 1
Page 1